Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the REGARDS study

Ethnicity and Disease

Volumn 20, Issue 3, 2010, Pages 282-289

  Durant, Raegan W ^a   McClure, Leslie A ^b   Halanych, Jewell H ^a   Lewis, Cora E ^a   Prineas, Ronald J ^c   Glasser, Stephen P ^a   Safford, Monika M ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Disparities; Hypertension; Trust

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CAUCASIAN; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH SERVICE; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; PATIENT ATTITUDE; PHYSICIAN; RACE DIFFERENCE; SELF REPORT; SYSTOLIC BLOOD PRESSURE; TRUST; AFRICAN AMERICAN; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; ETHNOLOGY; HEALTH PERSONNEL ATTITUDE; LONGITUDINAL STUDY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED STATES;

AFRICAN AMERICANS; AGED; ATTITUDE OF HEALTH PERSONNEL; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; RISK FACTORS; TREATMENT OUTCOME; TRUST; UNITED STATES;

EID: 78049435276     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Howard G., Prineas R., Moy C., et al. Racial and geographic differences in awareness, treatment, and control of hypertension: The REasons for Geographic and Racial Differences in Stroke Study. Stroke. 2006;37(5):1171-1178. (Pubitemid 43731857)
2. Ostchega Y., Hughes J.P., Wright J.D., McDowell M.A., Louis T. Are demographic characteristics, health care access and utilization, and comorbid conditions associated with hypertension among US adults? Am J Hypertens. 2008;21(2):159-165. (Pubitemid 351231564)
3. Victor R.G., Leonard D., Hess P., et al. Factors Associated With Hypertension Awareness, Treatment, and Control in Dallas County, Texas. Arch Intern Med. 2008;168(12):1285-1293. (Pubitemid 351930835)
4. Hertz R.P., Unger A.N., Cornell J.A., Saunders E. Racial Disparities in Hypertension Prevalence, Awareness, and Management. Arch Intern Med. 2005;165(18):2098-2104. (Pubitemid 41434584)
5. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997.
6. Wright J.T., Jr, Dunn J.K., Cutler J.A., et al. Outcomes in hypertensive Black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293(13): 1595-1608. (Pubitemid 40471790)
7. Williams B. Recent hypertension trials: Implications and controversies. J Am Coll Cardiol. 2005;45(6):813-827 (Pubitemid 40342804)
8. Hajjar I., Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199-206. (Pubitemid 37430058)
9. Kramer H., Han C., Post W., et al. Racial/ Ethnic differences in hypertension and hypertension treatment and control in the multiethnic study of atherosclerosis (MESA). Am J Hypertens. 2004;17(10):963-970. (Pubitemid 39361670)
10. Safford M.M., Halanych J.H., Lewis C.E., Levine D., Houser S., Howard G. Understanding racial disparities in hypertension control: Intensity of hypertension medication treatment in the REGARDS study. Ethn Dis. 2007;17(3):421-426. (Pubitemid 47606747)
11. Spruill T.M., Gerin W., Ogedegbe G., et al. Socioeconomic and psychosocial factors mediate race differences in nocturnal blood pressure dipping. Am J Hypertens. 2009;22(6):637-642
12. Cooper D.C., Ziegler M.G., Nelesen R.A., Dimsdale J.E. Racial differences in the impact of social support on nocturnal blood pressure. Psychosom Med. 2009;71(5):524-531
13. Kayaniyil S., Gravely-Witts S., Steward D.E., et al. Degree and correlates of patient trust in their cardiologist. J Eval Clin Pract. 2009; 15(4):634-640
14. Lukoschek P. African Americans' beliefs and attitudes regarding hypertension and its treatment: A qualitative study. J Health Care Poor Underserved. 2003;14(4):566-587. (Pubitemid 38553149)
15. He J., Munter P., Chen J., Rocella E.J., Streiffer R.H., Whelton P.K. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002; 162(9):1051-1058. (Pubitemid 34492536)
16. Hall M.A., Muntner P., Chen J., et al. Measuring patients' trust in their primary care providers. Med Care Res Rev. 2002;59(3):293-318. (Pubitemid 34875754)
17. Cooper L.A., Beach M.C., Johnson R.L., et al. Delving below the surface: Understanding how race and ethnicity influence relationships in health care. J Gen Intern Med. 2006;21:S21-S27.
18. Doescher M.P., Saver B.G., Franks P., Fiscella K. Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med. 2000;9(10):1156-1163. (Pubitemid 32014714)
19. Jacobs E.A., Rolle I., Ferrans C.E., Whitaker E.E., Warnecke R.B. Understanding African Americans'views of the trustworthiness of physicians. J Gen Intern Med. 2006;21(6):642-647. (Pubitemid 43801496)
20. Rawaf M.M., Kressin N.R. Exploring racial and sociodemographic trends in physician behavior, physician trust and their association with blood pressure control. J Natl Med Assoc. 2007;99(11):1248-1254. (Pubitemid 350252924)
21. Piette J.D., Heisler M., Krein S., Kerr E.A. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165(15):1749-1755. (Pubitemid 41138963)
22. Howard V.J., Cushman M., Pullet L., Gomez C.R., Go R.C., Prineas R.J., et al. The reasons for geographic and racial differences in stroke study: Objectives and design. Neuroepidemiology. 2005;25(3):135-143. (Pubitemid 41207066)
23. Chobanian A.V., Barkis G.L., Black H.R., CushmanW.C., Green L.A., Izzo J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289(19):2560-2571.
24. Rosendorff C., Black H.R., Cannon C.P., Gersh B.J., Gore J., Izzo J.L., Jr, et al. Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115(21):2761-2788. (Pubitemid 46842793)
25. Safran D.G., Kosinski M., Tarlov A.R., Rogers W.H., Taira D.H., Lieberman N., et al. The primary care assessment survey: Tests of data quality and measurement performance. Med Care. 1998;36(5):728-739. (Pubitemid 128456428)
26. FAQ: What is the Difference Between Urban and Rural? 2004 [cited 2009 July 7, 2009]. Available from: hhttps://ask.census.gov/ cgi-bin/askcensus.cfg/ php/enduser/std-alp. php?p-sid5lNDPAtLj. Last accessed June 4, 2010.
27. Ware J., Jr, Kosinski M., Keller S.D. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233 (Pubitemid 126433231)
28. Morisky D.E.S., Green L.W.D., Levine D.M. Concurrent and predictive validity of a selfreported measure of medication adherence. Med Care. 1986;24(1):67-74. (Pubitemid 16125389)
29. SAS, SAS/STAT Version 9.1. Cary, NC: SAS Institute Inc; 2004.
30. Halbert C.H., Armstrong K., Gandy O.H., Jr, Shaker L. Racial differences in trust in health care providers. Arch Intern Med. 2006;166(8): 896-901.
31. Hall M.A., Dugan E., Zheng B., Mishra A.K. Trust in physicians and medical institutions: What is it, can it be measured, and does it matter? Milbank Q. 2001;79(4):613-639. (Pubitemid 33636207)
32. Bloch M.J., Betancourt J., Green A. Overcoming racial and ethnic disparities in blood pressure control: A patient-centered approach to crosscultural communication. J Clin Hypertens. 2008;10(8):589-591.
33. Lee Y.Y., Lin J.L. The effects of trust in physician on self-efficacy, adherence and diabetes outcomes. Soc Sci Med. 2009;68(6):1060-1068.
34. Nguyen G.C., LaVeist T.A., Harris M.L., Datta L.W., Bayless T.M., Brant S.R. Patient trust-inphysician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflammatory Bowel Disease. 2009;15(8):1233-1239.
35. Thom D.H., et al. Development and evaluation of a cultural competency training curriculum. BMC Med Educ. 2006;6:38.
36. McKinstry B., Ashcroft R.E., Car J., Freeman G.K., Sheikh A. Interventions for improving patients' trust in doctors and groups of doctors. Cochrane Database Syst Rev. 2006;3: CD004134.
37. Martin L.R., Williams S.L., Haskard K.B., Dimatteo M.R. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3): 189-199.
38. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Levin R., Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age, gender, and race. Am J Public Health. 1996;86(12):1805-1808.
39. Ogedegbe G. Barriers to optimal hypertension control. J ClinHypertens. 2008;10(8):644-646.
40. Hyman D.J., Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7): 479-486. (Pubitemid 32758499)
41. King W.D. Examining African Americans'mistrust of the health care system: Expanding the research question. Commentary: "Race and trust in the health care system." Public Health Rep. 2003;118(4):366-367. (Pubitemid 36828341)
42. Garber M.C., Nau D.P., Erickson S.R., Aikens J.E., Lawrence J.B. The concordance of self-report with other measures of medication adherence: A summary of the literature. Med Care. 2004; 42(7):649-652.
43. Morris A.B., Li J., Kroenke K., Bruner-England T.E., Young J.M., Murray M.D. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26(4):483-492.